Ally Financial enters the final stretch before its October 20 earnings date with a fresh downgrade from Wells Fargo landing on top of a stock already down 10% over the past month, turning what was a caution signal a week ago into a more crowded bearish setup.
The most newsworthy development this week is the analyst shift. Wells Fargo's Donald Fandetti cut ALLY from Overweight to Equal-Weight on September 30, slashing his target from $55 to $42. That downgrade carries weight because Fandetti had been a bull, raising his target to $55 as recently as late June. The move joins a broader pattern of target compression: Citigroup trimmed to $50 from $58 on September 25, and Truist cut to $50 from $51 on September 23. The consensus mean target now sits at $51.95, implying roughly 37% upside to the $37.81 close, but that gap reflects a Street that has been consistently surprised by how far the stock has fallen, not a stable bullish conviction. The direction of travel is unambiguously downward across the analyst community this month, even among those maintaining Buy ratings.
Short positioning has continued building in parallel. Bears have added about 7.8% to their position over the past week, lifting short interest to 4.9% of the free float, or roughly 15 million shares. That is up from 12.8 million shares at the start of September, a monthly increase of around 17%. The build has been stepped rather than concentrated, with a clear jump on September 23 when shorts added more than one million shares in a single session, and the pace has held since. Despite the increase in positioned shorts, the borrow market remains loose: availability is at 5,540%, meaning there are roughly 55 shares available to borrow for every one already lent out. Cost to borrow has actually fallen sharply, dropping 32% over the week to just 0.24%. This is not a squeeze setup. The lending pool is deep, borrow is cheap, and shorts face no structural pressure to cover.
Options continue to carry a defensive lean, though the signal has moderated slightly from last week's more extreme reading. The put/call ratio is at 0.91, up from the 20-day average of 0.71 and roughly 1.4 standard deviations above that mean. A week ago the PCR was at 0.88 with a z-score above 2; the ratio has moved higher in absolute terms but the 20-day mean has also drifted up as defensive readings have been absorbed into the baseline. The message remains the same: options traders are buying more downside protection than normal ahead of October 20, but the setup is cautious rather than panicked.
The fundamental debate is simple. Bulls point to a stabilised core consumer auto portfolio at $83.9 billion, improving margins, and a valuation that looks cheap: the stock trades at roughly 6.2 times earnings and 0.76 times book. Bears counter that commercial auto shrank 5.9% to $21.6 billion, net financing revenues are sliding, and Ally's concentrated exposure to auto credit leaves it vulnerable if charge-off trends worsen. The valuation case is getting louder as the price falls, but the price-to-book multiple has compressed 8% over the past 30 days, suggesting the market is not yet treating the cheapness as a floor. The ORTEX analyst recommendation divergence factor scores in the 97th percentile, meaning the gap between the most bullish and most bearish targets is unusually wide, which typically reflects genuine uncertainty rather than consensus mispricing.
On the institutional register, Berkshire Hathaway last reported 27 million shares as of June 30, a reduction of 2 million shares from the prior period. BlackRock added just over 530,000 shares through August 31 to reach 28.6 million. Neither move is dramatic, but the Berkshire trim is worth noting given its symbolic weight in a stock that has long been associated with value investing. Insider activity over the past 90 days has been a net negative, with about 10,000 shares sold on balance, though the only open-market transactions were the CRO's planned 10b5-1 sales; no officer or director made a discretionary open-market purchase during the period.
The two most recent earnings prints tell a cautious earnings-reaction story: ALLY fell 1.9% the day after Q2 results in July and a further 3.1% over the following five days, and dropped 2.7% the day after Q1 results in April with a five-day follow-through of 8.3%. The stock has consistently underperformed into and after results. With the October 20 print now 20 days away, the focus shifts to whether credit quality and net interest margin commentary can change that pattern, or whether the Wells Fargo downgrade proves to be an early read on what management has to say.
See the live data behind this article on ORTEX.
Open ALLY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
